Literature DB >> 22408887

A current update on osteonecrosis of the jaw and bisphosphonates.

Yazdana Arrain1, Tahir Masud.   

Abstract

Bisphosphonates are effective drugs used to treat important medical conditions affecting the skeleton, such as malignancy and osteoporosis. Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is a rare but painful condition that can affect quality of life. Healthcare professionals need to be aware of this potential side-effect of bisphosphonates, as well as ways to minimize its occurrence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22408887     DOI: 10.12968/denu.2011.38.10.672

Source DB:  PubMed          Journal:  Dent Update        ISSN: 0305-5000


  4 in total

1.  Medication-related osteonecrosis of the jaw: a dentist's nightmare.

Authors:  Arvind Muthukrishnan; Laliytha Bijai Kumar; Gomathi Ramalingam
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.

Authors:  K Sun; J M Liu; H X Sun; N Lu; G Ning
Journal:  Osteoporos Int       Date:  2012-10-06       Impact factor: 4.507

Review 3.  Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis.

Authors:  H Devlin; J Greenwall-Cohen; J Benton; T L Goodwin; A Littlewood; K Horner
Journal:  Br Dent J       Date:  2017-11-17       Impact factor: 1.626

4.  Low-magnitude high-frequency loading, by whole-body vibration, accelerates early implant osseointegration in ovariectomized rats.

Authors:  Yong-Qiang Liang; Meng-Chun Qi; Jiang Xu; Juan Xu; Hua-Wei Liu; Wei Dong; Jin-Yuan Li; Min Hu
Journal:  Mol Med Rep       Date:  2014-09-23       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.